leadf
logo-loader
viewAvacta Group PLC
(
AIM:AVCT
)

BioIndustry Association marks 'golden age of biotech'

Dr Martin Turner who's head of policy and public affairs at the BioIndustry Association tells Proactive London it's a golden age of biotech currently with many more people wanting to get involved and invest in the sector. He says for newcomers to the space it's important they familiarise themselves with the clinical trial process as well as the different types of therapies and the science behind them. He says that as traditional sectors continue to suffer with the market disruption brought about by coronavirus, biopharma and healthcare is one of the few economic sectors to have largely escaped the global downturn.

Quick facts: Avacta Group PLC

Follow
AIM:AVCT

Price: 113 GBX

Market Cap: £286.63 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Redx Pharma presents at European Society for Medical Oncology (ESMO) Congress

Redx Pharma PLC's (LON:REDX) Lisa Anson joins Proactive London on the same day as the company present research at the European Society for Medical Oncology (ESMO) Congress. The firm presented the data from the phase I trial of its RXC004 monotherapy study which is their lead drug candidate,...

7 hours, 3 minutes ago

2 min read